Affiliations 

  • 1 Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. chaichan@health.moph.go.th
  • 2 , Sanofi, Singapore
  • 3 Faculty of Medicine, Udayana University, Bali, Indonesia
  • 4 Department of Medicine, Putrajaya Hospital, Putrajaya, Malaysia
  • 5 St. Luke's Medical Center, Manila, Philippines
  • 6 Cheng Hsin General Hospital, Taipei, Taiwan
  • 7 United Medical Practice, Hong Kong SAR, China
Diabetes Ther, 2017 Dec;8(6):1197-1214.
PMID: 29094298 DOI: 10.1007/s13300-017-0322-z

Abstract

Various data have demonstrated inadequate glycemic control amongst Asians with type 2 diabetes mellitus (T2DM), possibly on account of suboptimal titration of basal insulin-an issue which needs to be further examined. Here we review the available global and Asia-specific data on titration of basal insulin, with a focus on the use of insulin glargine 100 U/mL (Gla-100). We also discuss clinical evidence on the efficacy and safety of titrating Gla-100, different approaches to titration, including some of the latest technological advancements, and guidance on the titration of basal insulin from international and local Asian guidelines. The authors also provide their recommendations for the initiation and titration of basal insulin for Asian populations. Discussion of the data included in this review and in relation to the authors' clinical experience with treating T2DM in Asian patients is also included. Briefly, clinical studies demonstrate the achievement of adequate glycemic control in adults with T2DM through titration of Gla-100. However, studies investigating approaches to titration, specifically in Asian populations, are lacking and need to be conducted. Given that the management of insulin therapy is a multidisciplinary team effort involving endocrinologists, primary care physicians, nurse educators, and patients, greater resources and education targeted at these groups are needed regarding the optimal titration of basal insulin. Technological advancements in the form of mobile or web-based applications for automated dose adjustment can aid different stakeholders in optimizing the dose of basal insulin, enabling a larger number of patients in Asia to reach their target glycemic goals with improved outcomes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications